NO20001413L - Synergistisk sammensetning samt fremgangsmÕter ved behandling av neoplasier og svulster samt for Õ restaurere eller forsterke hematopoese - Google Patents
Synergistisk sammensetning samt fremgangsmÕter ved behandling av neoplasier og svulster samt for Õ restaurere eller forsterke hematopoeseInfo
- Publication number
- NO20001413L NO20001413L NO20001413A NO20001413A NO20001413L NO 20001413 L NO20001413 L NO 20001413L NO 20001413 A NO20001413 A NO 20001413A NO 20001413 A NO20001413 A NO 20001413A NO 20001413 L NO20001413 L NO 20001413L
- Authority
- NO
- Norway
- Prior art keywords
- haematopoiesis
- neoplasms
- restoration
- tumors
- enhancement
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 2
- 238000000034 method Methods 0.000 title 1
- 230000002195 synergetic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93335997A | 1997-09-18 | 1997-09-18 | |
PCT/US1998/018495 WO1999013912A1 (en) | 1997-09-18 | 1998-09-17 | Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20001413D0 NO20001413D0 (no) | 2000-03-17 |
NO20001413L true NO20001413L (no) | 2000-05-18 |
Family
ID=25463798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001413A NO20001413L (no) | 1997-09-18 | 2000-03-17 | Synergistisk sammensetning samt fremgangsmÕter ved behandling av neoplasier og svulster samt for Õ restaurere eller forsterke hematopoese |
Country Status (19)
Country | Link |
---|---|
US (4) | US6998125B2 (no) |
EP (1) | EP1015031A4 (no) |
JP (1) | JP2001516727A (no) |
KR (1) | KR100540267B1 (no) |
CN (1) | CN1234413C (no) |
AR (1) | AR013012A1 (no) |
AU (1) | AU742216B2 (no) |
CA (1) | CA2303178A1 (no) |
CO (1) | CO4790100A1 (no) |
HK (1) | HK1033653A1 (no) |
IL (2) | IL134937A0 (no) |
IN (1) | IN190792B (no) |
MY (1) | MY131805A (no) |
NO (1) | NO20001413L (no) |
RU (1) | RU2219947C2 (no) |
SA (1) | SA98190719B1 (no) |
TW (1) | TWI252108B (no) |
WO (1) | WO1999013912A1 (no) |
ZA (1) | ZA988461B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197311B1 (en) * | 1991-07-25 | 2001-03-06 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
CN1406140A (zh) * | 2000-02-28 | 2003-03-26 | 吉倪塞思公司 | 纳米胶囊包封系统与方法 |
US7244232B2 (en) * | 2001-03-07 | 2007-07-17 | Biomed Solutions, Llc | Process for identifying cancerous and/or metastatic cells of a living organism |
US20040038303A1 (en) * | 2002-04-08 | 2004-02-26 | Unger Gretchen M. | Biologic modulations with nanoparticles |
US7491395B2 (en) | 2002-11-20 | 2009-02-17 | Bestewil Holding B.V. | Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination |
EP2204190A1 (en) | 2003-07-15 | 2010-07-07 | Chugai Seiyaku Kabushiki Kaisha | IgM production by transformed cells and methods for quantifying said IgM production |
EP1781700B1 (en) | 2004-08-03 | 2014-03-19 | TransTech Pharma, LLC | Rage fusion proteins and methods of use |
KR20070057818A (ko) * | 2004-08-03 | 2007-06-07 | 트랜스테크 파르마, 인크. | Rage 융합 단백질 및 이의 사용 방법 |
ES2431632T3 (es) * | 2005-12-23 | 2013-11-27 | Gcoder Systems Ab | Patrón de posicionamiento |
US20090004190A1 (en) * | 2006-02-09 | 2009-01-01 | Mjalli Adnan M M | Rage Fusion Proteins And Methods Of Use |
EP2380983A3 (en) | 2006-05-05 | 2012-12-05 | TransTech Pharma Inc. | RAGE fusion proteins, formulations, and methods of use thereof |
WO2008100470A2 (en) * | 2007-02-15 | 2008-08-21 | Transtech Pharma, Inc. | Rage - immunoglobulin fusion proteins |
EP2215108A4 (en) | 2007-10-23 | 2012-07-04 | Univ Colorado | COMPETITIVE INHIBITORS OF THE EXPRESSION OF THE CONSTANT CHAIN AND / OR THE ECTOPIC CLIP BINDING |
WO2010122460A1 (en) | 2009-04-20 | 2010-10-28 | Pfizer Inc. | Control of protein glycosylation and compositions and methods relating thereto |
PE20121689A1 (es) * | 2009-10-09 | 2012-12-14 | Sanofi Sa | Polipeptidos para union al receptor para productos finales de glicosilacion avanzada asi como composiciones y metodos que implican a los mismos |
CA2817250A1 (en) * | 2010-11-18 | 2012-05-24 | The General Hospital Corporation | Novel compositions and uses of anti-hypertension agents for cancer therapy |
WO2013078286A1 (en) * | 2011-11-22 | 2013-05-30 | Cornell University | Methods for stimulating hematopoietic recovery by inhibiting tgf beta signaling |
EP3705498A1 (en) | 2013-08-22 | 2020-09-09 | Acceleron Pharma Inc. | Tgf-beta receptor type ii variants and uses thereof |
JP6679593B2 (ja) | 2014-09-03 | 2020-04-15 | ジーンセグエス,インコーポレイテッド | 療法用ナノ粒子および関連する組成物、方法、およびシステム |
US9884900B2 (en) | 2015-08-04 | 2018-02-06 | Acceleron Pharma Inc. | Methods for treating Janus kinase-associated disorders by administering soluble transforming growth factor beta type II receptor |
DK3628049T3 (da) | 2017-05-04 | 2023-08-14 | Acceleron Pharma Inc | Tgf-beta-receptortype-ii-fusionsproteiner og anvendelser deraf |
CA3093078A1 (en) | 2018-03-06 | 2019-09-12 | The Trustees Of The University Of Pennsylvania | Prostate-specific membrane antigen cars and methods of use thereof |
CN114814223A (zh) * | 2022-04-20 | 2022-07-29 | 昆明市妇幼保健院 | 一种用于监测及控制疟原虫治疗的系统及设备 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4052A (en) * | 1845-05-13 | Tktjss | ||
US20020004052A1 (en) * | 1990-05-08 | 2002-01-10 | David Berd | Composition comprising a tumor cell extract and method of using the composition |
US5585103A (en) * | 1991-07-25 | 1996-12-17 | Idec Pharmaceutical Corporation | Induction of cytotoxic T-lymphocyte responses |
US6197311B1 (en) * | 1991-07-25 | 2001-03-06 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
US5709860A (en) * | 1991-07-25 | 1998-01-20 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
JPH08504763A (ja) | 1992-10-29 | 1996-05-21 | セルトリックス ファーマシューティカルズ,インコーポレイテッド | 治療薬としてのTGF−βレセプターフラグメントの使用 |
US5514670A (en) | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
US5932212A (en) * | 1996-05-24 | 1999-08-03 | Altus Biologics, Inc. | Crosslinked protein crystal formulations and their use as catalysts in organic solvents |
-
1998
- 1998-09-16 ZA ZA988461A patent/ZA988461B/xx unknown
- 1998-09-16 MY MYPI98004237A patent/MY131805A/en unknown
- 1998-09-17 KR KR1020007002864A patent/KR100540267B1/ko not_active IP Right Cessation
- 1998-09-17 JP JP2000511527A patent/JP2001516727A/ja active Pending
- 1998-09-17 CN CNB988112809A patent/CN1234413C/zh not_active Expired - Fee Related
- 1998-09-17 AU AU95658/98A patent/AU742216B2/en not_active Ceased
- 1998-09-17 CA CA002303178A patent/CA2303178A1/en not_active Abandoned
- 1998-09-17 EP EP98949313A patent/EP1015031A4/en not_active Withdrawn
- 1998-09-17 WO PCT/US1998/018495 patent/WO1999013912A1/en not_active Application Discontinuation
- 1998-09-17 IL IL13493798A patent/IL134937A0/xx not_active IP Right Cessation
- 1998-09-17 CO CO98053593A patent/CO4790100A1/es unknown
- 1998-09-17 RU RU2000109595/14A patent/RU2219947C2/ru not_active IP Right Cessation
- 1998-09-17 AR ARP980104649A patent/AR013012A1/es not_active Application Discontinuation
- 1998-09-17 IN IN2797DE1998 patent/IN190792B/en unknown
- 1998-11-04 SA SA98190719A patent/SA98190719B1/ar unknown
-
1999
- 1999-01-29 TW TW087115599A patent/TWI252108B/zh not_active IP Right Cessation
-
2000
- 2000-03-07 IL IL134937A patent/IL134937A/en unknown
- 2000-03-17 NO NO20001413A patent/NO20001413L/no not_active Application Discontinuation
-
2001
- 2001-05-14 US US09/853,581 patent/US6998125B2/en not_active Expired - Lifetime
- 2001-05-14 US US09/853,580 patent/US20010018054A1/en not_active Abandoned
- 2001-06-19 HK HK01104231A patent/HK1033653A1/xx not_active IP Right Cessation
-
2003
- 2003-12-24 US US10/743,739 patent/US20040137014A1/en not_active Abandoned
-
2005
- 2005-12-12 US US11/298,567 patent/US20060153848A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2219947C2 (ru) | 2003-12-27 |
US20010018054A1 (en) | 2001-08-30 |
AU9565898A (en) | 1999-04-05 |
US20040137014A1 (en) | 2004-07-15 |
US20010019715A1 (en) | 2001-09-06 |
ZA988461B (en) | 1999-03-30 |
AR013012A1 (es) | 2000-11-22 |
CO4790100A1 (es) | 1999-05-31 |
NO20001413D0 (no) | 2000-03-17 |
IN190792B (no) | 2003-08-23 |
TWI252108B (en) | 2006-04-01 |
EP1015031A1 (en) | 2000-07-05 |
CN1279616A (zh) | 2001-01-10 |
MY131805A (en) | 2007-09-28 |
KR20010024109A (ko) | 2001-03-26 |
CN1234413C (zh) | 2006-01-04 |
AU742216B2 (en) | 2001-12-20 |
KR100540267B1 (ko) | 2006-01-10 |
CA2303178A1 (en) | 1999-03-25 |
JP2001516727A (ja) | 2001-10-02 |
IL134937A0 (en) | 2001-05-20 |
US20060153848A1 (en) | 2006-07-13 |
EP1015031A4 (en) | 2004-03-17 |
SA98190719B1 (ar) | 2006-08-06 |
IL134937A (en) | 2008-04-13 |
US6998125B2 (en) | 2006-02-14 |
HK1033653A1 (en) | 2001-09-14 |
WO1999013912A1 (en) | 1999-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20001413L (no) | Synergistisk sammensetning samt fremgangsmÕter ved behandling av neoplasier og svulster samt for Õ restaurere eller forsterke hematopoese | |
BR9508886A (pt) | Compostos e métodos para o tratamento de câncer | |
PT936859E (pt) | Composicao e metodo para o tratamento de plantas com quimicos exogenos | |
NO992641D0 (no) | Blandinger og fremgangsmÕter for behandling eller forhindring av betennelsessykdommer | |
NO985652D0 (no) | Anvendelse av naaladaseinhibitorer ved behandling av kreft | |
FI971969A0 (fi) | Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä | |
DE69518919T2 (de) | Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung | |
BR9711530A (pt) | Combina-Æo de terapia para tratamento de psicoses | |
BR9406178A (pt) | Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo | |
DE69821667D1 (de) | Kardioverter zur Behandlung von Vorhofflattern | |
DE69836304D1 (de) | Vorrichtung zur Vermeidung von Vorhof-Fibrillation | |
BR9708362A (pt) | Utilização de uma quantidade eficaz de um extrato e processo de tratamento cosmético | |
BR9504072A (pt) | Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit | |
DE69806801D1 (de) | Galenische präparation zur prävention und behandlung von hepatokarzinomen | |
ID21332A (id) | Metode dan komposisi untuk pengobatan dan pencegahan hiperurikemia | |
BR9710534A (pt) | Tratamento da superf¡cie de metal | |
DE69836209D1 (de) | Vorbeugung und behandlunhg des hepatozellulären krebses | |
NO20001412D0 (no) | Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser | |
NO20003229L (no) | Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer | |
FI965008A0 (fi) | Koostumukset ja menetelmät kasvainten hoitamiseksi | |
NO972426D0 (no) | Metode for anvendelse av triarylethylenderivater ved behandling og forhindring av osteoporose | |
BR9612283A (pt) | Composição para o tratamento de manchas em peças de roupa e métodos de tratamento | |
DE69825319D1 (de) | Präparat zur vorbeugung und behandlung von entzündungen | |
FI961380A (fi) | Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi | |
IL141426A0 (en) | Compositions and methods for the treatment of tumor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |